This initiative will provide MDVIP's affiliated physicians with a genomic testing service from Redwood Shores, Calif.-based Navigenics.
Navigenics will provide MDVIP patients and their affiliated physicians with insight into their personal genetic predisposition for developing certain medical conditions where primary or secondary prevention could improve health outcomes.
"We have for many years been closely watching the field of genomic testing evolve into a tool that can enhance and inform the practice of preventive medicine," said Edward Goldman, MD, CEO of MDVIP. "We believe that Navigenics' preventive genomics service has the potential to be an innovation that could significantly enhance patient care."
The Navigenics test will identify individuals' genetic markers for developing such conditions as type 2 diabetes, cancer, heart attack, and celiac disease. Navigenics will also provide board-certified Genetic Counselors that will collaborate with MDVIP physicians to help patients chart and implement a personalized wellness course to help decrease their overall risk, delay disease onset, or prevent it altogether.